Autologous Tissue Repair to 2018. Products, Indications, Markets and Forecasts - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Autologous Tissue Repair to 2018. Products, Indications, Markets and Forecasts


Autologous Tissue Repair to 2018. Products, Indications, Markets and Forecasts

PR Newswire

DUBLIN, February 14, 2014 /PRNewswire/ --

Dublin  - Research and Markets (http://www.researchandmarkets.com/research/n7sxmf/autologous_tissue) has announced the addition of the "Autologous Tissue Repair to 2018. Products, Indications, Markets and Forecasts" report to their offering. 


     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


The ability to isolate, purify and re-inject patient-derived cells with regenerative properties has led to a number of therapeutic products for the treatment of refractory injuries and wounds. Autologous tissue repair is having an impact on a number of areas, including cardiovascular medicine, refractory wound care, orthopedics, and surgical medicine. The potential economic benefits of autologous tissue repair are significant, as an aging population struggles with intractable ailments that historically have required numerous follow-up provider visits. While several autologous therapies require remote processing, the number of therapeutic autologous products that can be processed at the point-of-care is increasing. This report details the autologous tissue repair products and development programs of twenty-seven separate companies in seven countries - companies working to shape the future of tissue regeneration.

Highlights

  • Analyzes and evaluates autologous tissue repair products and product candidates and assesses the market potential for existing and probable future products
  • Examines tissue repair demand drivers and evolving market factors
  • Forecasts the impact of tissue regeneration technology and therapeutics on application segments and projects probable future developments
  • Profiles autologous tissue repair market participants, their technology, product development activity, and business strategies
  • Provides forecasts and market data to 2018

Key Topics Covered: 

Executive Summary

Autologous Tissue Repair - Market Structure
Tissue Repair Market Segments
Demographics and Growth
Competitive Landscape
Demand Drivers
Risk Factors

Therapeutic Application Segment Analysis
CNS
Orthopedic
Bone Graft Fixation
Ligament Repair
Surgical
Cardiovascular Procedures
Neurosurgical Procedures
Plastic/Cosmetic Surgery
Wound Care
Acute Trauma
Burns
Diabetic Ulcers
Pressure Ulcers
Venous Ulcers

Autologous Therapeutics - Product Analysis, Outlook and Forecasts

Chondrocyte Harvesting
Cardiovascular Grafts
Epidermal Grafts
Macrophage Activation
Skin Cell Suspension
Thrombin/Platelet Gels
Platelet Rich Plasma
Stem Cell Isolation

Market Factors
Clinical Trial Enrollment
FDA Guidelines
Reimbursement
Evolving Patient Demographics
Point-of-Care Processing
Protocols and End-Points

Autologous Tissue Repair Company Profiles 

For more information visit http://www.researchandmarkets.com/research/n7sxmf/autologous_tissue

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
88%
Borrow lightly from EMA's pathway program?
4%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here